Strategic COA Development Modus Outcomes positions itself as a Center of Excellence for developing Clinical Outcomes Assessments (COAs), offering de novo COA creation, adaptation, and expert validation. This suggests opportunities to engage sponsors early in product development to design COAs that meet regulatory and promotional needs, potentially expanding into partnerships with pharma and device companies seeking rigorous, patient-centered measurement.

Regulatory & Clinical Integration Their approach integrates clinical, regulatory, and measurement perspectives across design and evaluation phases. Sales opportunities exist with clients pursuing integrated evidence generation for regulatory submissions, real-world evidence programs, and post-market commitments where robust COA data supports labeling claims and health technology assessments.

Global Reach As an international firm with presence in the US, UK, and France, Modus Outcomes can support multinational clinical programs and aligned COA strategies across regions, reducing regulatory burden for sponsors running global trials and enabling cohesive patient-centered measurement across markets.

Advanced Analytics & Qualitative-Quantitative The firm emphasizes stochastic measurement models and mixed-methods design, offering sophisticated analytics plans for CSR and scientific communication. This presents a sales angle to sponsors needing rigorous, publication-ready analyses and flexible methodologies to capture meaningful treatment benefits in diverse patient populations.

Acquisition Backing & Reputation Acquisition by THREAD in 2021 signals integration with a broader decentralized trial capability, lending credibility and expanded HTN capabilities. This can be leveraged in conversations with potential clients about enhanced data quality, technology-enabled outcomes, and a proven track record of scaling COA programs within larger clinical research ecosystems.